TrialLeukemia research2013

Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age.

Carlos E Vigil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.